Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns

The molecular mechanisms of bladder cancer development and progression are not clear. Bladder cancer is an important focus for epidemiological studies and understanding clinical implications. The primary aim of prevention is achieved by limiting exposure to non-genetic risk factors, such as smoking,...

Full description

Saved in:

Bibliographic Details
Published in:	Current medicinal chemistry Vol. 28; no. 41; p. 8517
Main Authors:	Mikhaleva, Liudmila M, Pechnikova, Valentina V, Pshikhachev, Akhmed M, Rogov, Konstantin A, Gusniev, Magomed A, Patsap, Olga I, Vasyukova, Olesya A, Akopyan, Emma P, Beylerli, Ozal, Somasundaram, Siva G, Kirkland, Cecil E, Aliev, Gjumrakch
Format:	Journal Article
Language:	English
Published:	United Arab Emirates 01-01-2021
Subjects:	Biomarkers Humans Mutation Neoplasm Invasiveness Risk Factors Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - genetics risk factors bladder cancer pathogenesis histological classification of bladder cancer NMIBC molecular pathways of bladder cancer PD-L1 MIBC immunohistochemistry Bladder cancer
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The molecular mechanisms of bladder cancer development and progression are not clear. Bladder cancer is an important focus for epidemiological studies and understanding clinical implications. The primary aim of prevention is achieved by limiting exposure to non-genetic risk factors, such as smoking, diet, arsenic in drinking water, or aromatic amines at work or elsewhere. Current therapies for bladder cancer are affected by tumor morphology and associated acquired genetic mutations. A literature search was performed using PubMed, Scopus, ResearchGate, Google, MEDLINE, and ScienceDirect databases to find studies of bladder cancer published between 1984 and early 2020. The focus was articles that address epidemiological risk factors and underlying pathophysiological mechanisms. Articles were selected that enabled our review of these factors as well as molecular and structural patterns. There are multiple views of bladder cancer. The literature offers several novel insights regarding the development and progression of bladder cancer and possible biomarkers that may be useful in clinical and diagnostic practice. There are several molecular pathways associated with bladder cancer that are frequently updated. In addition, genetic subtypes of bladder tumors are not distinguished clearly which requires future more detailed analysis.
ISSN:	1875-533X
DOI:	10.2174/0929867328666210309111731